1. Home
  2. SYNA vs ABCL Comparison

SYNA vs ABCL Comparison

Compare SYNA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synaptics Incorporated $0.001 Par Value

SYNA

Synaptics Incorporated $0.001 Par Value

HOLD

Current Price

$97.74

Market Cap

4.2B

Sector

Technology

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$11.47

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYNA
ABCL
Founded
1986
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.5B
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
SYNA
ABCL
Price
$97.74
$11.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$100.78
$8.40
AVG Volume (30 Days)
599.1K
8.7M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
$663,588,000.00
$75,128,000.00
Revenue This Year
$12.63
N/A
Revenue Next Year
$9.67
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
21.04
160.56
52 Week Low
$58.28
$2.75
52 Week High
$149.11
$12.15

Technical Indicators

Market Signals
Indicator
SYNA
ABCL
Relative Strength Index (RSI) 37.51 77.52
Support Level $71.55 $3.38
Resistance Level $147.97 N/A
Average True Range (ATR) 4.04 0.84
MACD -0.24 0.38
Stochastic Oscillator 4.11 92.57

Price Performance

Historical Comparison
SYNA
ABCL

About SYNA Synaptics Incorporated $0.001 Par Value

Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: